开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
E Blaurock-Busch
Gadolinium-Based Contrast Agents (GBCA) are intravenous drugs used in diagnostic imaging procedures to enhance the quality of magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA). Recent FDA alerts concerning potential side effects increased patient and medical concerns. We checked if gadolinium remains in the body system longer than pharmaceutical information states and since a growing number of chelation therapists uses chelating agents to remove gadolinium that may have been stored in the body, we checked how effective chelation agents are. Our studies indicate that in the case of gadolinium, chelation does not seem to be an option.